RE:RE:New Institutional holders & Egrifta salesAbit more digging.
You can access their historical holdings also and they dont show holding any in Dec 2017. It also shows they paid an average price of 7.24. So they must have accumulated in Jan/Feb after the extension was announced and in the run up to approval. Nice timing!
(btw SPCEO I dont see where you got 1.3million shares.Bloomberg.ca shows 670,000 and that is the only holding in any of their mutual fund. Maybe they hold some in other investment vehicles, idk, but I'd check your number)
PoorOpinion wrote: FWIW, a bit of detective work.
All Artisans shares are being held in their Artisan International Small Cap Fund
https://www.artisanpartners.com/content/dam/documents/holdings/vfund/2018/1q/InternationalSmCap-Holdings-1Q18-vFund.pdf That fund strategy
https://www.artisanpartners.com/content/dam/documents/investment-process/vr/Investment-Process-Global-Equity-Team-vR.pdf from their buy/sell strategy
"
Stock markets move share prices around far more than the change in the underlying fundamental value of a company. This creates opportunities for us to buy good companies when the market has lost faith in them " you can see why they picked theratech :)
SPCEO1 wrote: On Bloomberg, Artisan Partners now shows up as holding almost 1.3 million shares and is the third largest shareholder listed (Ibelieve there are other shareholders who hold positions larger than even oours but they don't file their holdings because they don't have to). Royal Bank, through the O'Shaughnessy Funds, is the fourth largest holder listed on Bloomberg with 780,000 shares. Blackrock also has established a small holding. So, while someone is clearly keeping a lid on the stock with their selling recently, there have been some institutiions getting involved. There are surely more who would want to own the stock but since none of the large holders are interested in selling, they can't get big positions without pushing the share price up and they are not willing to do that yet.
Meanwhile,we have seen a pick-up in Egrifta sales in recent weeks based on the Bloomberg data. Nothing huge but there has likely been a positive impact now that the salespeople are getting into see the doctors to tell them about Trogarzo.Every little bit helps!